Address Concerns About Thrombosis With COVID-19 Vaccines

Patients will ask you whether COVID-19 vaccines increase clot risk.

This is due to reports of serious blood clots along with thrombocytopenia after the Johnson & Johnson/Janssen vaccine in the U.S...and the AstraZeneca vaccine in other countries. Both are viral vector vaccines.

Now the Janssen vaccine emergency use authorization (EUA) fact sheets will warn about this issue.

Get unlimited access through an Enterprise license

Hospital Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Not sold to individuals